Quick Answer
VACCINEX, INC. reported Net Income of -$18.63 million for fiscal year 2024.
VACCINEX, INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2024 | -$18.63M | +8.0% |
| 2023 | -$20.25M | -2.2% |
| 2022 | -$19.82M | +11.5% |
| 2021 | -$22.38M | +22.4% |
| 2020 | -$28.85M | +9.5% |
| 2019 | -$31.86M | -7.9% |
| 2018 | -$29.52M | -57.7% |
| 2017 | -$18.72M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2024 | -$5.73M | -16.7% | -1.8% |
| June 30, 2024 | -$5.63M | +20.2% | -44.5% |
| March 31, 2024 | -$3.90M | +21.5% | +20.7% |
| September 30, 2023 | -$4.91M | -3.2% | +30.4% |
| June 30, 2023 | -$7.06M | -31.2% | -42.3% |
| March 31, 2023 | -$4.96M | -8.0% | -4.3% |
| September 30, 2022 | -$4.76M | +8.6% | +11.6% |
| June 30, 2022 | -$5.38M | +9.8% | -17.1% |
- VACCINEX, INC. showed an increase of +8.0% in Net Income compared to the prior fiscal year.
- Over the 2017–2024 period, VACCINEX, INC.’s net income has grown by 0.5% (from -$18.72 million to -$18.63 million).
- The most recent figure is from VACCINEX, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: